Clorox (NYSE:CLX) Earns Neutral Rating from DA Davidson

DA Davidson reaffirmed their neutral rating on shares of Clorox (NYSE:CLX) in a research report report published on Wednesday, Benzinga reports. DA Davidson currently has a $162.00 price objective on the stock.

Several other research firms have also issued reports on CLX. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $145.00 to $152.00 and gave the company a neutral rating in a report on Thursday, January 18th. Morgan Stanley reissued an equal weight rating and issued a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Barclays decreased their target price on Clorox from $148.00 to $136.00 and set an underweight rating for the company in a research note on Wednesday, April 10th. UBS Group boosted their price target on Clorox from $145.00 to $170.00 and gave the company a neutral rating in a research note on Friday, February 2nd. Finally, Citigroup cut their price target on Clorox from $165.00 to $155.00 and set a neutral rating on the stock in a report on Tuesday. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. According to MarketBeat, the company currently has a consensus rating of Hold and a consensus target price of $148.63.

Clorox Trading Down 0.1 %

NYSE CLX opened at $142.29 on Wednesday. Clorox has a 12 month low of $114.68 and a 12 month high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The firm has a market capitalization of $17.66 billion, a PE ratio of 225.86, a price-to-earnings-growth ratio of 2.19 and a beta of 0.43. The business’s 50-day moving average price is $150.40 and its two-hundred day moving average price is $141.69.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the business posted $0.98 earnings per share. The firm’s revenue was up 16.0% on a year-over-year basis. On average, analysts expect that Clorox will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.37%. Clorox’s dividend payout ratio is presently 761.92%.

Institutional Investors Weigh In On Clorox

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Clorox by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock worth $2,010,622,000 after acquiring an additional 44,344 shares during the last quarter. BlackRock Inc. lifted its position in shares of Clorox by 2.1% during the 1st quarter. BlackRock Inc. now owns 9,463,011 shares of the company’s stock worth $1,497,427,000 after buying an additional 195,348 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Clorox by 3.8% in the first quarter. Geode Capital Management LLC now owns 2,725,410 shares of the company’s stock valued at $430,349,000 after acquiring an additional 100,920 shares in the last quarter. FMR LLC increased its position in shares of Clorox by 17.4% during the third quarter. FMR LLC now owns 2,415,054 shares of the company’s stock valued at $316,517,000 after acquiring an additional 357,964 shares during the last quarter. Finally, Stifel Financial Corp lifted its holdings in Clorox by 2.2% during the third quarter. Stifel Financial Corp now owns 2,184,875 shares of the company’s stock worth $286,356,000 after acquiring an additional 47,879 shares during the period. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.